Severe CD4 Lymphocytopenia in Patients With Multiple Sclerosis Treated With Fingolimod

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.340
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cryptococcal Meningoencephalitis Treated With Fingolimod in a Patient With Multiple Sclerosis

Turkiye Klinikleri Journal of Case Reports
2019English

Primary Cutaneous Cryptococcus in a Patient With Multiple Sclerosis Treated With Fingolimod

JAMA Neurology
Neurology
2016English

Multiple Immune Abnormalities in a Patient With Idiopathic CD4+ T-Lymphocytopenia

Internal Medicine
Internal MedicineMedicine
2009English

Idiopathic CD4 Lymphocytopenia With Adrenal Histoplasmosis

International Journal of Medical Science and Public Health
2014English

Real-World Outcomes in Fingolimod-Treated Patients With Multiple Sclerosis in the Czech Republic: Results From the 12-Month GOLEMS Study

Clinical Drug Investigation
MedicinePharmacology
2016English

A Randomized Study to Evaluate the Effect of Exercise on Fatigue in People With Relapsing–remitting Multiple Sclerosis Treated With Fingolimod

Multiple Sclerosis Journal - Experimental, Translational and Clinical
2018English

Health State Utilities in Patients With Relapsing Remitting Multiple Sclerosis Treated With Cladribine Tablets

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Mortality in Patients With Multiple Sclerosis

Neurology
Neurology
2013English

HDL-cholesterol Elevation Associated With Fingolimod and Dimethyl Fumarate Therapies in Multiple Sclerosis

Multiple Sclerosis Journal - Experimental, Translational and Clinical
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy